| Trial ID: | L3944 |
| Source ID: | NCT01296412
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01296412/results
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: sitagliptin|DRUG: liraglutide|DRUG: glimepiride|DRUG: metformin
|
| Outcome Measures: |
Primary: Change From Baseline in Hemoglobin A1c (A1C), A1C is measured as percent. Thus, this change from baseline reflects the Week 26 A1C percent minus the Week 0 A1C percent., Baseline and Week 26 | Secondary: Change From Baseline in Fasting Plasma Glucose (FPG), Change from baseline at Week 26 is defined as Week 26 minus Week 0., Baseline and Week 26|Percentage of Participants Reaching A1C Goal of <7.0%, Week 26|Percentage of Participants Reaching A1C Goal of <6.5%, Week 26
|
| Sponsor/Collaborators: |
Sponsor: Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
653
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-03-11
|
| Completion Date: |
2012-02-29
|
| Results First Posted: |
2013-03-15
|
| Last Update Posted: |
2017-06-09
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01296412
|
